Why It Matters
Ellis Hospital is like so many other US hospitals facing unprecedented financial pressure as Medicare and Medicaid reimbursement reforms accelerate and Medicaid DSH payment cuts totaling $8 billion annually took effect October 1, 2025.
Its final quarter lobbying push aims to preserve critical funding streams: DSH payments, Medicare wage index adjustments, medical education support, and 340B drug pricing program protections. The hospital’s strategy targets both appropriations and legislative initiatives like hospital-at-home program extensions.
Success means preserving reimbursement rates; failure could accelerate the closure crisis threatening the 734 hospitals nationwide at closure risk
By the Numbers
Ellis Hospital spent $50,000 on federal lobbying in the fourth quarter of 2025 through Envision Strategy LLC. The Schenectady hospital has maintained this relationship since 2019, filing 28 disclosures totaling $1,245,000 over six years—representing substantial federal advocacy investment.
The lobbying team includes two healthcare veterans: Brett Heimov, former administrative assistant to Rep. Jerry Nadler (D-NY), and Stephen E. Schultz, former Joint Economic Committee staffer. Ellis maintains consistent focus on Medicare/Medicaid policy, hospital funding, medical education, and the 340B program.
The Agenda
Ellis Hospital is lobbying on healthcare policy issues critical to hospital finances. Current priorities include Medicare and Medicaid reimbursement policy, hospital funding mechanisms, medical education funding, and budget matters. Specifically, Ellis advocates on Area Wage Index adjustments, Disproportionate Share Hospital payments, the 340B drug pricing program, and Health Professional Shortage Area designations. The hospital’s agenda mirrors sector-wide concerns, with health systems including UPMC and Sutter Health lobbying on identical Medicare and Medicaid payment issues.
Broader Context
Ellis’s fourth quarter 2025 lobbying occurs amid a critical moment for American hospitals. Medicaid DSH payment cuts, reduced funding by over 50 percent. Congress is actively debating hospital viability through the Hospital Inpatient Services Modernization Act and Nurse Staffing Standards for Hospital Patient Safety Act.
Nearly one-third of U.S. rural hospitals face serious financial risk, with 92 rural hospitals already closed. Congressional hearings on HHS budgets and the 340B program signal intense legislative focus on hospital funding.
Between The Lines
Congressional activity reveals intense focus on hospital viability. The House Appropriations Committee held HHS budget hearings, while the Senate HELP Committee examined FY2026 budget requests—both critical for Medicare and Medicaid funding levels Ellis depends on.
Several bills could reshape hospital finances. The Nurse Staffing Standards Act proposes mandatory nurse-to-patient ratios with significant budget implications. Bipartisan support exists for hospital survival, with Senators Scott (R-SC) and Warnock (D-GA) leading Hospital at Home extensions.
Competitive Landscape
Ellis operates in a crowded healthcare lobbying ecosystem. UPMC spent $250,000 in the secone quarter of 2025 on identical priorities: Medicaid DSH payments, 340B programs, and medical education funding. Sutter Health deployed $80,000 for Medicare/Medicaid payments and wage index adjustments. Ellis shares lobbying firm Envision Strategy with other New York hospitals including Glens Falls Hospital and Cayuga Medical Center.
The Bottom Line
Ellis Hospital is maintaining steady federal advocacy amid healthcare sector crisis. The hospital’s $50,000 final quarter 2025 investment reflects industry alarm over Medicaid DSH cuts and Medicare pressures. Major systems including UPMC and Sutter Health are simultaneously lobbying on identical issues, indicating sector-wide rather than Ellis-specific concerns.
Access the Legis1 platform for comprehensive political news, data, and insights.